Page last updated: 2024-10-22

aristolochic acid i and Heart Failure

aristolochic acid i has been researched along with Heart Failure in 2 studies

aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lam, NT1
Currie, PD1
Lieschke, GJ1
Rosenthal, NA1
Kaye, DM1
Huang, CC1
Chen, PC1
Huang, CW1
Yu, J1

Other Studies

2 other studies available for aristolochic acid i and Heart Failure

ArticleYear
Nerve growth factor stimulates cardiac regeneration via cardiomyocyte proliferation in experimental heart failure.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Animals; Animals, Genetically Modified; Apoptosis; Aristolochic Acids; Cell Proliferation; Heart; He

2012
Aristolochic Acid induces heart failure in zebrafish embryos that is mediated by inflammation.
    Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 100, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aristolochic Acids; Cyclooxygenase 2; Cyclooxygen

2007